‌

US Patent 10774139 ANGPTL8-binding agents and methods of use thereof

Patent 10774139 was granted and assigned to NGM Biopharmaceuticals on September, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

NGM Biopharmaceuticals

Current Assignee

NGM Biopharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10774139

Date of Patent

September 15, 2020

Patent Application Number

16184548

Date Filed

November 8, 2018

Patent Citations

‌

US Patent 10071139 Methods for treatment of conditions associated with elevated triglycerides with an ANGPTL8 polypeptide fragment

Patent Citations Received

‌

US Patent 11977081 ANGPTL8 assay and uses thereof

‌

US Patent 11566067 Methods of lowering triglyceride levels with an ANGPTL8-binding antibody or antigen-binding fragment thereof

Patent Primary Examiner

‌

Zachary C Howard

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10774139 ANGPTL8-binding agents and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API